159 related articles for article (PubMed ID: 25886083)
1. Clinical symptoms and self-reported disease severity among patients with psoriasis - Implications for psoriasis management.
Korman NJ; Zhao Y; Li Y; Liao M; Tran MH
J Dermatolog Treat; 2015; 26(6):514-9. PubMed ID: 25886083
[TBL] [Abstract][Full Text] [Related]
2. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.
Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632793
[TBL] [Abstract][Full Text] [Related]
3. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA.
Korman NJ; Zhao Y; Pike J; Roberts J
Clin Exp Dermatol; 2016 Jul; 41(5):514-21. PubMed ID: 27061102
[TBL] [Abstract][Full Text] [Related]
4. Patient satisfaction with current psoriasis treatment: a real-world study in the USA.
Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267186
[TBL] [Abstract][Full Text] [Related]
5. The relationship between symptoms and patient characteristics among psoriasis patients.
Bilac C; Ermertcan AT; Bilac DB; Deveci A; Horasan GD
Indian J Dermatol Venereol Leprol; 2009; 75(5):551. PubMed ID: 19736461
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
[TBL] [Abstract][Full Text] [Related]
7. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study.
Mrowietz U; Chouela EN; Mallbris L; Stefanidis D; Marino V; Pedersen R; Boggs RL
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1114-20. PubMed ID: 25376448
[TBL] [Abstract][Full Text] [Related]
8. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey.
Griffiths CEM; Jo SJ; Naldi L; Romiti R; Guevara-Sangines E; Howe T; Pietri G; Gilloteau I; Richardson C; Tian H; Augustin M
Br J Dermatol; 2018 Jul; 179(1):173-181. PubMed ID: 29328510
[TBL] [Abstract][Full Text] [Related]
9. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
10. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of symptoms experienced by patients with different clinical types of psoriasis.
Sampogna F; Gisondi P; Melchi CF; Amerio P; Girolomoni G; Abeni D;
Br J Dermatol; 2004 Sep; 151(3):594-9. PubMed ID: 15377345
[TBL] [Abstract][Full Text] [Related]
12. Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.
Martin ML; McCarrier KP; Chiou CF; Gordon K; Kimball AB; Van Voorhees AS; Gottlieb AB; Huang X; Globe D; Chau D; Viswanathan HN; Kricorian G
J Dermatolog Treat; 2013 Aug; 24(4):255-60. PubMed ID: 23249143
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.
Pariser D; Schenkel B; Carter C; Farahi K; Brown TM; Ellis CN;
J Dermatolog Treat; 2016; 27(1):19-26. PubMed ID: 26138406
[TBL] [Abstract][Full Text] [Related]
14. Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
Sobell JM; Foley P; Toth D; Mrowietz U; Girolomoni G; Goncalves J; Day RM; Chen R; Yosipovitch G
Acta Derm Venereol; 2016 May; 96(4):514-20. PubMed ID: 26837052
[TBL] [Abstract][Full Text] [Related]
15. Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Feldman SR; Green L; Kimball AB; Siu K; Zhao Y; Herrera V; Nyirady J; Alexis AF
J Dermatolog Treat; 2017 Dec; 28(8):716-721. PubMed ID: 28737440
[TBL] [Abstract][Full Text] [Related]
16. Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics.
Ljosaa TM; Rustoen T; Mörk C; Stubhaug A; Miaskowski C; Paul SM; Wahl AK
Acta Derm Venereol; 2010; 90(1):39-45. PubMed ID: 20107724
[TBL] [Abstract][Full Text] [Related]
17. Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis.
Viswanathan HN; Chau D; Milmont CE; Yang W; Erondu N; Revicki DA; Klekotka P
J Dermatolog Treat; 2015 Jun; 26(3):235-9. PubMed ID: 25078334
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis disease severity affects patient satisfaction with treatment.
Korman NJ; Zhao Y; Lu J; Tran MH
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436965
[TBL] [Abstract][Full Text] [Related]
19. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.
Menter A; Kosinski M; Bresnahan BW; Papp KA; Ware JE
J Drugs Dermatol; 2004; 3(1):27-38. PubMed ID: 14964744
[TBL] [Abstract][Full Text] [Related]
20. Itching in patients suffering from psoriasis.
Szepietowski JC; Reich A; Wiśnicka B
Acta Dermatovenerol Croat; 2002 Dec; 10(4):221-6. PubMed ID: 12588672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
